GB0612844D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0612844D0
GB0612844D0 GB0612844A GB0612844A GB0612844D0 GB 0612844 D0 GB0612844 D0 GB 0612844D0 GB 0612844 A GB0612844 A GB 0612844A GB 0612844 A GB0612844 A GB 0612844A GB 0612844 D0 GB0612844 D0 GB 0612844D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0612844A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB0612844A priority Critical patent/GB0612844D0/en
Publication of GB0612844D0 publication Critical patent/GB0612844D0/en
Priority to CA002655540A priority patent/CA2655540A1/en
Priority to US11/768,339 priority patent/US7700599B2/en
Priority to TW096122969A priority patent/TWI391386B/en
Priority to PT07765616T priority patent/PT2041093E/en
Priority to CN2007800324070A priority patent/CN101511791B/en
Priority to AT07765616T priority patent/ATE465150T1/en
Priority to ES07765616T priority patent/ES2344484T3/en
Priority to JP2009517160A priority patent/JP5028484B2/en
Priority to PL07765616T priority patent/PL2041093T3/en
Priority to ARP070102835A priority patent/AR061656A1/en
Priority to DK07765616.3T priority patent/DK2041093T3/en
Priority to NZ573450A priority patent/NZ573450A/en
Priority to EP07765616A priority patent/EP2041093B1/en
Priority to DE602007006019T priority patent/DE602007006019D1/en
Priority to BRPI0713443-6A priority patent/BRPI0713443A2/en
Priority to PE2007000819A priority patent/PE20080345A1/en
Priority to PCT/EP2007/056342 priority patent/WO2008000729A1/en
Priority to AU2007263712A priority patent/AU2007263712B2/en
Priority to SI200730257T priority patent/SI2041093T1/en
Priority to EA200970065A priority patent/EA015820B1/en
Priority to KR1020087031612A priority patent/KR20090031688A/en
Priority to MX2009000110A priority patent/MX2009000110A/en
Priority to JO2007261A priority patent/JO2645B1/en
Priority to IL195900A priority patent/IL195900A0/en
Priority to CR10497A priority patent/CR10497A/en
Priority to MYPI20085319A priority patent/MY147677A/en
Priority to MA31526A priority patent/MA30539B1/en
Priority to NO20090266A priority patent/NO20090266L/en
Priority to US12/417,176 priority patent/US8853218B2/en
Priority to HK09106727.8A priority patent/HK1127608A1/en
Priority to HR20100284T priority patent/HRP20100284T1/en
Priority to CY20101100521T priority patent/CY1110190T1/en
Ceased legal-status Critical Current

Links

GB0612844A 2006-06-28 2006-06-28 Compounds Ceased GB0612844D0 (en)

Priority Applications (33)

Application Number Priority Date Filing Date Title
GB0612844A GB0612844D0 (en) 2006-06-28 2006-06-28 Compounds
JO2007261A JO2645B1 (en) 2006-06-28 2007-06-26 Compounds
PE2007000819A PE20080345A1 (en) 2006-06-28 2007-06-26 PIPERAZINE DERIVATIVES AS AGONISTS OF THE GPR38 RECEPTOR
AU2007263712A AU2007263712B2 (en) 2006-06-28 2007-06-26 Piperazinyl derivatives useful in the treatment of GPR38 receptor mediated diseases
TW096122969A TWI391386B (en) 2006-06-28 2007-06-26 Compounds
PCT/EP2007/056342 WO2008000729A1 (en) 2006-06-28 2007-06-26 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
CN2007800324070A CN101511791B (en) 2006-06-28 2007-06-26 Piperazinyl derivatives useful in the treatment of GPR38 receptor mediated diseases
AT07765616T ATE465150T1 (en) 2006-06-28 2007-06-26 PIPERAZINYL DERIVATIVES SUITABLE FOR THE TREATMENT OF DISEASES MEDIATED BY THE GPR38 RECEPTOR
ES07765616T ES2344484T3 (en) 2006-06-28 2007-06-26 PIPERAZINYL DERIVATIVES USEFUL IN THE TREATMENT OF DISEASES MEDIATED BY THE GPR38 RECEIVER
US11/768,339 US7700599B2 (en) 2006-06-28 2007-06-26 Gpr38 Receptor Agonists
PL07765616T PL2041093T3 (en) 2006-06-28 2007-06-26 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
ARP070102835A AR061656A1 (en) 2006-06-28 2007-06-26 BENCILPIPERAZINE COMPOSITE, ITS USE TO PREPARE A MEDICINAL PRODUCT, PHARMACEUTICAL COMPOSITION THAT INCLUDES IT AND PROCESSES FOR THE PREPARATION OF COMPOSITION AND COMPOSITION
DK07765616.3T DK2041093T3 (en) 2006-06-28 2007-06-26 For the treatment of GPR38 receptor, diseases mediate useful piperazinyl derivatives
NZ573450A NZ573450A (en) 2006-06-28 2007-06-26 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
EP07765616A EP2041093B1 (en) 2006-06-28 2007-06-26 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
SI200730257T SI2041093T1 (en) 2006-06-28 2007-06-26 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
BRPI0713443-6A BRPI0713443A2 (en) 2006-06-28 2007-06-26 PIPERAZINILY DERIVATIVES USEFUL IN THE TREATMENT OF MEDICAL DISEASES BY GPR38 RECEIVER, USE AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH COMPOUNDS AND PREPARATION PROCESSES
CA002655540A CA2655540A1 (en) 2006-06-28 2007-06-26 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
PT07765616T PT2041093E (en) 2006-06-28 2007-06-26 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
JP2009517160A JP5028484B2 (en) 2006-06-28 2007-06-26 Piperazinyl derivatives useful for the treatment of GPR38 receptor mediated diseases
DE602007006019T DE602007006019D1 (en) 2006-06-28 2007-06-26 PIPERAZINE DERIVATIVES SUITABLE FOR THE TREATMENT OF DISEASES MEDIATED BY THE GPR38 RECEPTOR
EA200970065A EA015820B1 (en) 2006-06-28 2007-06-26 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
KR1020087031612A KR20090031688A (en) 2006-06-28 2007-06-26 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
MX2009000110A MX2009000110A (en) 2006-06-28 2007-06-26 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases.
CR10497A CR10497A (en) 2006-06-28 2008-12-11 USEFUL PIPERAZINYL DERIVATIVES IN THE TREATMENT OF DISEASES MEDIATED BY THE GPR38 RECEIVER
IL195900A IL195900A0 (en) 2006-06-28 2008-12-11 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
MYPI20085319A MY147677A (en) 2006-06-28 2008-12-24 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
MA31526A MA30539B1 (en) 2006-06-28 2008-12-30 PIPERAZINYL DERIVATIVES USEFUL IN THE TREATMENT OF DISEASES INDUCED BY THE GPR38 RECEPTOR.
NO20090266A NO20090266L (en) 2006-06-28 2009-01-16 Piperazinyl derivatives useful in the treatment of GPR38 receptor-mediated diseases
US12/417,176 US8853218B2 (en) 2006-06-28 2009-04-02 Compounds
HK09106727.8A HK1127608A1 (en) 2006-06-28 2009-07-22 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
HR20100284T HRP20100284T1 (en) 2006-06-28 2010-05-21 Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases
CY20101100521T CY1110190T1 (en) 2006-06-28 2010-06-11 Piperazinyl derivative useful in the treatment of diseases mediated by the GPR38 receptor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0612844A GB0612844D0 (en) 2006-06-28 2006-06-28 Compounds

Publications (1)

Publication Number Publication Date
GB0612844D0 true GB0612844D0 (en) 2006-08-09

Family

ID=36888248

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0612844A Ceased GB0612844D0 (en) 2006-06-28 2006-06-28 Compounds

Country Status (2)

Country Link
CN (1) CN101511791B (en)
GB (1) GB0612844D0 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013007145A2 (en) * 2010-09-27 2016-06-14 Daiichi Sankyo Co Ltd pharmacologically acceptable compound or salt, medicament, and use of the pharmacologically acceptable compound or salt

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6511980B2 (en) * 2000-05-05 2003-01-28 Ortho Mcneil Pharmaceutical, Inc. Substituted diamine derivatives useful as motilin antagonists
US7105682B2 (en) * 2001-01-12 2006-09-12 Amgen Inc. Substituted amine derivatives and methods of use

Also Published As

Publication number Publication date
CN101511791A (en) 2009-08-19
CN101511791B (en) 2012-06-20

Similar Documents

Publication Publication Date Title
GB0602424D0 (en) Compounds
GB0602046D0 (en) Compounds
GB0606876D0 (en) Compounds
GB0605786D0 (en) Compounds
EP1984379A4 (en) Anti-arenaviral compounds
GB0607175D0 (en) Compounds
GB0605785D0 (en) Compounds
GB0605784D0 (en) Compounds
EP2082022A4 (en) Compounds
GB0606913D0 (en) Compounds
EP2004174A4 (en) Naphthalenedione compounds
GB0602042D0 (en) Compounds
EP1973905A4 (en) Compounds
AP2009004767A0 (en) Cubstituted azolin-2-yl-amino compounds
EP2016069A4 (en) Bis-pyridinium compounds
GB0602560D0 (en) Compounds
GB0602412D0 (en) Compounds
GB0600427D0 (en) Compounds
GB0612844D0 (en) Compounds
GB0601505D0 (en) Compounds
GB0606880D0 (en) Compounds
GB0605589D0 (en) Compounds
GB0600426D0 (en) Compounds
GB0605414D0 (en) Compounds
GB0603551D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)